[HTML][HTML] Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer

XW Zhang, JY Li, L Li, WQ Hu, Y Tao, WY Gao… - Cell Death & …, 2023 - nature.com
The widespread application of antiandrogen therapies has aroused a significant increase in
the incidence of NEPC, a lethal form of the disease lacking efficient clinical treatments. Here …

[HTML][HTML] Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR

XW Zhang, L Li, WQ Hu, MN Hu, Y Tao, H Hu… - Cell Death & …, 2022 - nature.com
Despite the great advances in target therapy, lung cancer remains the top cause of cancer-
related death worldwide. G protein-coupled receptor neurokinin-1 (NK1R) is shown to play …

[HTML][HTML] The role of JNK in prostate cancer progression and therapeutic strategies

R Xu, J Hu - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Prostate cancer (PC), which has high morbidity and mortality among elderly men, is
becoming the most common malignancy in men. The progression of PC is associated with …

[HTML][HTML] Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach

M Di Donato, G Cernera, F Auricchio, A Migliaccio… - Cell Death …, 2018 - nature.com
Prostate cancer (PC) is the second leading cause of cancer death in men in Western society.
Current therapies for PC remain, however, unsatisfactory and PC frequently progresses …

Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3. 1

MC Markowski, C Bowen, EP Gelmann - Cancer research, 2008 - AACR
Inflammation of the prostate is a risk factor for the development of prostate cancer. In the
aging prostate, regions of inflammatory atrophy are foci for prostate epithelial cell …

Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation

C Le Magnen, RK Virk, A Dutta, JY Kim… - Disease models & …, 2018 - journals.biologists.com
Although it is known that inflammation plays a critical role in prostate tumorigenesis, the
underlying processes are not well understood. Based on analysis of genetically engineered …

[HTML][HTML] Identification of the neurokinin-1 receptor as targetable stratification factor for drug repurposing in pancreatic cancer

I Beirith, BW Renz, S Mudusetti, NS Ring, J Kolorz… - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma is the most common form of pancreatic
cancer. It is known for low life expectancies after diagnosis and very limited treatment …

Regulating NKX3. 1 stability and function: Post‐translational modifications and structural determinants

A Padmanabhan, V Rao, AM De Marzo… - The …, 2016 - Wiley Online Library
BACKGROUND The androgen‐regulated homeodomain transcription factor NKX3. 1 plays
roles in early prostate development and functions as a prostate‐specific tumor suppressor …

[HTML][HTML] The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer

C Blanc, A Moktefi, A Jolly, P De La Grange… - British Journal of …, 2023 - nature.com
Background Neuroendocrine prostate cancer (NEPC) is a multi-resistant variant of prostate
cancer (PCa) that has become a major challenge in clinics. Understanding the …

NKX3. 1 is regulated by protein kinase CK2 in prostate tumor cells

X Li, B Guan, S Maghami… - Molecular and cellular …, 2006 - Taylor & Francis
Diminished expression of NKX3. 1 is associated with prostate cancer progression in
humans, and in mice, loss of nkx3. 1 leads to epithelial cell proliferation and altered gene …